Clinical trial
Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate
NCT00238017 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00238017 |
|---|---|
| Title | Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate |
| Official title | A Randomized, Double Blind Trial on the Efficacy and Safety of Amodiaquine-Artesunate and Amodiaquine Alone in the Treatment of Children With Uncomplicated Falciparum Malaria |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | University for Development Studies, Tamale, Ghana Kintampo Health Research Centre, Ghana |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | amodiaquine-artesunate versus amodiaquine |
| Enrollment | 400 |
| Start date | Oct 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Oct 13, 2005 |
| Last update posted | Feb 2, 2006 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: